A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Public ClinicalTrials.gov record NCT06770933. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Double-Masked, Randomised, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety of Orally Administered VX-01 in Diabetic Retinopathy OF Non-Proliferative Type (NPDR)
Study identification
- NCT ID
- NCT06770933
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vantage Biosciences Ltd
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Interventions
- Placebo Drug
- VX-01 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 10, 2025
- Primary completion
- Feb 28, 2027
- Completion
- Feb 28, 2027
- Last update posted
- Jun 17, 2025
2025 – 2027
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina-Vitreous Associates Medical Group | Beverly Hills | California | 90211 | Not yet recruiting |
| Stanford Byers Eye Institute | Palo Alto | California | 94303 | Not yet recruiting |
| California Retina Consultants- Santa Barbara | Santa Barbara | California | 93103 | Not yet recruiting |
| Florida Retina Institute - Jacksonville Southside | Jacksonville | Florida | 32216 | Not yet recruiting |
| Retina Associates | Elmhurst | Illinois | 60126 | Not yet recruiting |
| Cumberland Valley Retina Consultants | Hagerstown | Maryland | 21740-5940 | Not yet recruiting |
| Erie Retina Research | Erie | Pennsylvania | 16507 | Not yet recruiting |
| Piedmont Eye Center | Lynchburg | Virginia | 24502 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06770933, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06770933 live on ClinicalTrials.gov.